BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 29, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Biocept, General Electric sales and marketing update

General Electric's Clarient Inc. subsidiary partnered with Biocept to commercialize the latter's OncoCEE-BR test in the U.S. to detect and analyze circulating tumor cells (CTCs) in blood from breast cancer patients and to assess epidermal growth factor receptor 2 (...

Read the full 197 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >